Angiotensin II and sodium balance affect the status of each other and both either separately or together can lead to an increase in blood pressure. They also can cause vascular and cardiac damage due to direct effects and effects mediated by the blood pressure increase. This paper reviews the important interactions among these three variables. Acute blood pressure elevation during sleeping but not during waking 
Introduction
Organ damage is a common accompaniment of hypertension and it is organ damage that determines morbidity and mortality (1) . While blood pressure is an important factor determining damage to the organs, other factors independent of blood pressure level have important effects on different organs. Organs are affected differently by these processes and this pa-Increased wall stress results from a rise in blood pressure. Stretching of cardiomyocytes causes local release of angiotensin II, which acts as an autocrine and paracrine factor to improve cardiac contraction and may lead to cardiac hypertrophy, thereby correcting the increased wall tension (8, 9) . Clinically it is often assumed that 24 h workload in a hypertensive patient is the determinant of LVH (10) . However over 24 h blood pressure varies markedly leading to different wall stress at different periods of the day associated with different systemic or local humoral environment. Thus, in the present study, we investigated whether wall stress or 24-h workload causes cardiac hypertrophy.
Angiotensin II was given intraperitoneally in 4 injections between 0800 and 1200 h. In this and all studies in rats, blood pressure was measured by telemetry as described previously (11) . Blood pressure was elevated markedly during this period ( Fig. 2) with little effect on 24 h blood pressure. A group of rats was given continuous angiotensin II by osmotic minipump. In this group blood pressure was markedly elevated over 24 h, and the level between 0800 and 1200 h was similar to that in the group given intermittent intraperitoneal injections. Heart size as measured by direct weight and by cardiac index increased to a similar extent in both groups (Fig. 2 ). The conclusion from this was that wall stress induced over a 4 h period could set in train the sequence of events that leads to LVH, and that wall stress was more important than 24-h workload.
In a reversal experiment, hypertension was created in rats using a 2K-1C Goldblatt model (12) . Rats were then treated with a large dose of captopril in their drinking water, which lowered blood pressure throughout the 24 h and caused redependently cause organ damage (2, 3) , and this organ damage in turn influences sodium excretion, angiotensin II, and blood pressure. These interactions make it difficult to dissect out the key factors that specifically influence organ damage. However, it is likely that organ damage would be greatest if sodium intake, angiotensin II, and blood pressure were all high, and that the deleterious effects of one could be prevented by reducing the level of another.
Angiotensin II and Cardiac Hypertrophy
Infusion of angiotensin II increases blood pressure and over a 2 week period increases left ventricular mass and medial thickness (3, 4) . If the rise in blood pressure were to be prevented by concomitant administration of hydralazine, it is possible that the left ventricular hypertrophy (LVH) might be prevented (4), although there is dissention on this issue (3). However, if right ventricular size is measured there is no increase in mass with angiotensin infusion. Likewise in the 2 kidney (K)-1 clip (C) (2K-1C) Goldblatt hypertensive rat model, which is an angiotensin II-dependent model, there is also no right ventricular hypertrophy (RVH), and blockade of the renin angiotensin system with either an angiotension converting enzyme (ACE) inhibitor or an angiotensin type 1 (AT1) receptor blocker reduces LVH but has no significant effect on right ventricular mass (5) .
The aortocaval fistula model of cardiac hypertrophy shows both RVH and LVH, and both are reduced by treatment with an ACE inhibitor or an AT1 receptor blocker (6, 7) . The overall interpretation of these results is that angiotensin II does not cause an increase in cardiac mass unless myocytes are exposed to an increased load, whether this is due to pressure or volume. Likewise volume load does not cause hypertrophy unless angiotensin II is present. Thus angiotensin II with either a volume or pressure load leads to cardiac myocyte hypertrophy, while if there is no load there is no hypertrophy. 
Fig. 2. Systolic blood pressure (SBP) during intermittent injections of angiotensin II (A II) over a 4-h period and cardiac index after 2 weeks of therapy compared with those in a sham-injected rat (control) and a rat receiving continuous (cont) A II infusion.
versal of cardiac hypertrophy. A separate group of rats were given captopril 15 mg/kg/day at 0800 h. This normalized blood pressure between 0800 and 1400 h, but had only a small effect on 24 h blood pressure, and from 2000 to 0800 h blood pressure was no different from that in the untreated controls. However, cardiac size was reduced to a similar extent to that with 24 h blood pressure control.
Importance of Blood Pressure Elevation at Different Periods of the Day
There is a contradiction inherent in the previous results. That is, in the acute elevation studies, 4 h of elevated blood pressure caused cardiac hypertrophy, while in the resolution studies, despite blood pressure being elevated for between 12 and 16 h, resolution occurred. The sleep cycle of rats is the reverse of the human sleep cycle: rats sleep from about 0700-1800 h. The previous group of experiments was therefore repeated, with the exception that blood pressure was acutely elevated between 2000 and 2400 h by giving 4 intraperitoneal injections of angiotensin II and blood pressure in the 2K-1C hypertensive rats was reduced by intraperitoneal captopril at 2000 h. In the first scenario there was no significant increase in cardiac size (Table 1 ) and in the second study captopril given to 2K-1C Goldblatt hypertensive rats at 2000 h caused no significant reduction in cardiac size. Thus it would appear from these results that blood pressure during sleep is an important determinant of the effect on cardiac size.
Interaction between Angiotensin II and Sodium Intake
Angiotensin II contributes to cardiac hypertrophy both through its elevation of blood pressure and through a function independent of blood pressure elevation. Similarly, high sodium chloride intake can elevate blood pressure and, by an independent effect, increase cardiac size. Angiotensin administration would tend to cause sodium retention, and these effects are complementary (Fig. 1) . However a high salt intake decreases angiotensin II level but cardiac hypertrophy still results. Thus the relative importance of angiotensin II and salt intake was studied.
In a series of studies by Morgan et al. (13) , angiotensin II was given to rats on a 0.4%, 1.0% or 4% NaCl diet. Blood pressure elevation over the period (2 weeks) of the study was similar among groups. However, the effect on cardiac index was different (Fig. 3) . The cardiac index in rats receiving 4% NaCl was greater than that in rats receiving 1% or 0.4% NaCl. Angiotensin increased cardiac size when administered to rats on a 1% or 4% NaCl diet, but there was no significant increase in rats on a 0.4% NaCl diet. The largest cardiac mass was that in rats receiving 4% NaCl angiotensin infusion.
Morgan et al. conducted regression experiments on rats made hypertensive for 3 weeks using the 2K-1C and the 1K-1C Goldblatt model (5) . Rats were then placed on 4% or 0.2% NaCl intake and given captopril 75 mg/kg/day in their drinking water. In contrast to the above mentioned studies on 2K-1C Goldblatt rats receiving 1% NaCl, there was only a small fall in blood pressure in rats on the 4% NaCl diet, and no resolution of cardiac size. In rats on the 0.2% NaCl diet, both blood pressure and cardiac size were normalized. In the 1K-1C Goldblatt rats, neither blood pressure nor cardiac index was altered in rats receiving either 1% or 4% NaCl when given captopril. However, in rats on a 0.2% NaCl diet, both blood pressure and cardiac index were normalized. Similar results were achieved when losartan was used instead of captopril. The dose of captopril used would be expected to block ACE over 24 h and also allow accumulation of bradykinin. Therefore, under condition of a high sodium intake, angiotensin II is not needed to cause cardiac hypertrophy, and bradykinin does not resolve cardiac hypertrophy. Likewise in these models a low sodium intake by itself does not cause resolution of either blood pressure or cardiac hypertrophy. Furthermore the presence of a high salt intake and angiotensin II caused the greatest cardiac hypertrophy. Results are given as the means SEM; n 8. p 0.01 compared with sleep administration.
Fig. 3. Effect of intermittent injection of angiotensin II (Ang II) between 0800-1200 h on cardiac size in rats with 3 different levels of sodium intake.

Combined Blockade of the Renin Angiotensin System
These studies were conducted in both spontaneously hypertensive rats (SHR) and Sprague Dawley rats (14, 15) . Perindopril 6 mg/kg/day and losartan 10 mg/kg/day were given by daily intraperitoneal injections at 0800 h. The behaviour, blood pressure, somatic growth, renal function and cardiac size were determined. The studies were done in rats receiving either 0.2% or 4% NaCl. Blood pressure fell acutely in both groups (Table 2 ). In the rats on the high NaCl diet, there was no further fall in blood pressure throughout the study and all other parameters remained constant. In rats on the 0.2% NaCl diet, the fall in blood pressure was progressive and rats died after 10-14 days of therapy unless drug administration was stopped. Cessation of drug administration or placing the rats on a high sodium intake reversed the process. After 10 days of drug administration, cardiac size was lower than in rats prior to starting the study, indicating that there was cardiac involution, while in rats on a high NaCl diet the cardiac size was not altered (Table 2) . Plasma renin composition rose 70-100 times in rats on combined blockade and 0.2% NaCl intake. This level was reduced to 20% of this value by 4% NaCl. In rats receiving low sodium intake combined therapy, angiotensinogen levels fell to 10% of the control values and were not altered by use of a high salt intake combined therapy (Table 2) . When large doses of ACE inhibitors and AT1 receptor blockers are administered, powerful compensating events take place to ensure that some angiotensin II activity still is present. Only when angiotensinogen levels are depleted do we truly have an animal that is "angiotensin free." If this is correct it emphasizes that angiotensin is essential for maintenance of cardiac growth, somatic growth and survival and the high NaCl intake may protect by preventing angiotensinogen depletion. However, an alternate proposal is that the high sodium intake reverses, by a different pathway, abnormalities in cell composition caused by the absence of angiotensin II. This is supported by the finding that a high salt intake can reverse a similar type syndrome produced in mice with AT1A, AT1B receptor knockout, angiotensinogen knockout and mice with no membrane bound ACE (16) (17) (18) .
Hypothesis for Interaction of Na Intake and Angiotensin II Causing Cardiac Hypertrophy
Cardiocytes continually produce H which must escape from cells, and this production is increased when workload rises. H exits the cells via sodium hydrogen exchange (NHE). This is a 1-for-1 relationship, i.e., 1 Na enters for each H that exits. However, the H inside the cell can also be neutralized by combining with 2HCO3 . This bicarbonate enters the cell by the Na , 2HCO3 cotransporter (NBC). Thus for the same entry of Na more H can be neutralized. If the neutralization can be shifted to the Na , 2HCO3 pathway, there will be less alteration in the cellular Na dynamics. Excess Na in the cell is removed by Na,K ATPase, but if it accumulates it will reduce the activity of the Na -Ca 2 countertransport, calcium will tend to accumulate in the cell, and this accumulation of calcium will then activate processes that lead to cell growth.
Angiotensin II exists preformed within cells and is released in response to cell stretch (wall stress) (9) . The angiotensin II increases the contractile response (19) , thereby responding to the initiating signal, but at the same time, additional H ions are produced and need to "exit" the cell. Angiotensin II by binding to the AT1 receptor increases NHE transport (20) , thereby allowing exit of H , but at the expense of an increase in cell sodium. The NBC transporter is also stimulated by angiotensin II but via the angiotensin type 2 (AT2) receptor (S. Sandmann and T. Unger: unpublished observations). By altering the ratio of the AT2 to the AT1 receptor, a greater correction of the H production could be achieved with less Na entry.
On a high sodium diet, circulating plasma renin and angiotensin II are reduced (Fig. 4) , which in turn causes upregulation of the number of AT1 receptors (21) . When an individual on a high sodium diet has acute cardiac stress, the local release of angiotensin II activates the NHE, and most of the correction of the increased H production occurs via this pathway. Low sodium intake, on the other hand, is associated with a high circulating angiotensin II level. This will downregulate the AT1 receptor, thereby increasing the Results are given as the means SEM; n 8-10. Mean cardiac mass of control group rats sacrificed at the start of the experiment. p 0.01 compared with rats receiving 0.2% NaCl. SBP, systolic blood pressure; PRA, plasma renin activity; A1, angiotensinogen.
AT2/AT1 receptor ratio. In addition, circulating angiotensin II acting via the AT1 receptor increases cellular Na , and there is some evidence that this can upregulate the AT2 receptor (22) . When an individual on a reduced sodium diet is exposed to acute blood pressure elevation and wall stress, angiotensin II is released to improve contractility. The correction of the increased H production is now primarily by the NBC, and thus less Na enters. This does not exceed the correction capacity of the Na, K ATPase. Thus the dynamics of cellular calcium are not altered and cardiac hypertrophy does not occur.
Clinical Correlations
Many of the experimental data have important clinical correlations. For example, high sodium intake causes LVH and vascular stiffness independent of blood pressure effects; Saltsensitive patients have a higher night time blood pressure and more vascular disease. If an individual's blood pressure does not fall at night, there is more LVH, more vascular disease and more death. Thus night time blood pressure in humans is an important determinant of morbidity and mortality.
Conclusion
Angiotensin II is an important and critical factor for normal human functioning. It is important in sodium and water homeostasis and in blood pressure control. It has multiple effects related to cell growth and function maintenance. Under conditions of stress or damage it plays an initial important role. However, under a number of circumstances initial important compensatory processes become deleterious and result in adverse outcomes. The relative actions of angiotensin II by the AT1 and AT2 receptors are important in determining the response of the heart. Activation of the AT1 receptor causes cell growth while activation of the AT2 receptor may have the opposite effect. The balance of AT1/AT2 receptors is altered by the sodium intake. Thus any discussion related to the effects of angiotensin II must take into account the sodium status of an individual. 
Fig. 4. Proposed interaction between
